Cargando…
Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
BACKGROUND: Animal studies suggest sphingolipids as an early marker of impaired glucose metabolism; however, research in humans is limited. We evaluated whether individual sphingolipid species were associated with fasting plasma glucose and incident impaired fasting glucose in a longitudinal cohort...
Autores principales: | Jensen, Paul N., Fretts, Amanda M., Yu, Chaoyu, Hoofnagle, Andrew N., Umans, Jason G., Howard, Barbara V., Sitlani, Colleen M., Siscovick, David S., King, Irena B., Sotoodehnia, Nona, McKnight, Barbara, Lemaitre, Rozenn N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444022/ https://www.ncbi.nlm.nih.gov/pubmed/30594552 http://dx.doi.org/10.1016/j.ebiom.2018.12.046 |
Ejemplares similares
-
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018) -
Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
por: Jensen, Paul N., et al.
Publicado: (2022) -
Plasma epoxyeicosatrienoic acids and dihydroxyeicosatrieonic acids, insulin, glucose and risk of diabetes: The strong heart study
por: Lemaitre, Rozenn N., et al.
Publicado: (2021) -
Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
por: Fretts, Amanda M., et al.
Publicado: (2021) -
Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study
por: Gharib, Arya R., et al.
Publicado: (2023)